Do analysts recommend CGC or ACB?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50

Does the media prefer CGC or ACB?

In the previous week, Aurora Cannabis had 7 more articles in the media than Canopy Growth. MarketBeat recorded 15 mentions for Aurora Cannabis and 8 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 0.92 beat Aurora Cannabis' score of 0.20 indicating that Canopy Growth is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Canopy Growth 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aurora Cannabis 3 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Neutral

Do analysts prefer CRON or ACB?

Cronos Group currently has a consensus price target of $2.30, suggesting a potential downside of 34.47%. Given Cronos Group's higher probable upside, equities analysts clearly believe Cronos Group is more favorable than Aurora Cannabis. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40 Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50

Does the media refer more to CRON or ACB?

In the previous week, Aurora Cannabis had 9 more articles in the media than Cronos Group. MarketBeat recorded 15 mentions for Aurora Cannabis and 6 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.46 beat Aurora Cannabis' score of 0.20 indicating that Cronos Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aurora Cannabis 3 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Neutral

Do analysts rate ACB or OGI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Do analysts rate ACB or SNDL?

SNDL has a consensus target price of $5.00, suggesting a potential upside of 264.96%. Given SNDL's higher probable upside, analysts plainly believe SNDL is more favorable than Aurora Cannabis. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50 SNDL 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher earnings & valuation, ACB or SNDL?

SNDL has higher revenue and earnings than Aurora Cannabis. SNDL is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aurora Cannabis $247.82M 1.05 -$88.13M -$1.41 N/A SNDL $677.32M 0.52 -$11.29M -$0.06 N/A

Is ACB or SNDL more profitable?

SNDL has a net margin of -2.36% compared to Aurora Cannabis' net margin of -32.26%. Aurora Cannabis' return on equity of 4.37% beat SNDL's return on equity. Company Net Margins Return on Equity Return on Assets Aurora Cannabis -32.26% 4.37% 3.45% SNDL -2.36% -2.01% -1.67%

Do analysts rate TLRY or ACB?

Tilray Brands currently has a consensus price target of $8.00, suggesting a potential upside of 63.93%. Given Tilray Brands' higher possible upside, research analysts clearly believe Tilray Brands is more favorable than Aurora Cannabis. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray Brands 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.43 Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50

Does the media prefer TLRY or ACB?

In the previous week, Tilray Brands had 4 more articles in the media than Aurora Cannabis. MarketBeat recorded 19 mentions for Tilray Brands and 15 mentions for Aurora Cannabis. Tilray Brands' average media sentiment score of 0.62 beat Aurora Cannabis' score of 0.20 indicating that Tilray Brands is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tilray Brands 6 Very Positive mention(s) 5 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Aurora Cannabis 3 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Neutral

Aurora Cannabis (ACB) Competitors

$4.01 +0.07 (+1.78%)

Closing price 08/25/2026 04:00 PM Eastern

Extended Trading

$3.98 -0.03 (-0.75%)

As of 08:20 AM Eastern

Compare

ACB vs. CGC, CRON, OGI, SNDL, and TLRY

Should you buy Aurora Cannabis stock or one of its competitors? Aurora Cannabis's main competitors and comparable companies include Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), and Tilray Brands (TLRY). Companies are selected based on similarities in market, industry, and size.

How does Aurora Cannabis compare to Canopy Growth?

Canopy Growth (NASDAQ:CGC) and Aurora Cannabis (NASDAQ:ACB) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation.

Aurora Cannabis has lower revenue, but higher earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$251.01M	1.92	-$190.29M	-$0.45	N/A
Aurora Cannabis	$247.82M	1.05	-$88.13M	-$1.41	N/A

In the previous week, Aurora Cannabis had 7 more articles in the media than Canopy Growth. MarketBeat recorded 15 mentions for Aurora Cannabis and 8 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 0.92 beat Aurora Cannabis' score of 0.20 indicating that Canopy Growth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Canopy Growth	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aurora Cannabis	3 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	1 Very Negative mention(s)	Neutral

Aurora Cannabis has a net margin of -32.26% compared to Canopy Growth's net margin of -65.33%. Aurora Cannabis' return on equity of 4.37% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-65.33%	-21.91%	-14.34%
Aurora Cannabis	-32.26%	4.37%	3.45%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 0.4% of Canopy Growth shares are held by insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Canopy Growth has a beta of 0.81, indicating that its share price is 19% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market.

Summary

Canopy Growth and Aurora Cannabis tied by winning 8 of the 16 factors compared between the two stocks.

How does Aurora Cannabis compare to Cronos Group?

Cronos Group (NASDAQ:CRON) and Aurora Cannabis (NASDAQ:ACB) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation and earnings.

Cronos Group currently has a consensus price target of $2.30, suggesting a potential downside of 34.47%. Given Cronos Group's higher probable upside, equities analysts clearly believe Cronos Group is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, Aurora Cannabis had 9 more articles in the media than Cronos Group. MarketBeat recorded 15 mentions for Aurora Cannabis and 6 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.46 beat Aurora Cannabis' score of 0.20 indicating that Cronos Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aurora Cannabis	3 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	1 Very Negative mention(s)	Neutral

Cronos Group has higher earnings, but lower revenue than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	8.88	-$9.45M	$0.20	17.55
Aurora Cannabis	$247.82M	1.05	-$88.13M	-$1.41	N/A

Cronos Group has a net margin of 39.08% compared to Aurora Cannabis' net margin of -32.26%. Cronos Group's return on equity of 4.85% beat Aurora Cannabis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	39.08%	4.85%	4.62%
Aurora Cannabis	-32.26%	4.37%	3.45%

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Cronos Group has a beta of 0.9, suggesting that its stock price is 10% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.58, suggesting that its stock price is 42% less volatile than the broader market.

Summary

Cronos Group beats Aurora Cannabis on 12 of the 17 factors compared between the two stocks.

How does Aurora Cannabis compare to Organigram Global?

Aurora Cannabis (NASDAQ:ACB) and Organigram Global (NASDAQ:OGI) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings, dividends and media sentiment.

Organigram Global has lower revenue, but higher earnings than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$247.82M	1.05	-$88.13M	-$1.41	N/A
Organigram Global	$185.07M	0.97	-$17.70M	$0.46	2.76

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Organigram Global has a net margin of 28.14% compared to Aurora Cannabis' net margin of -32.26%. Aurora Cannabis' return on equity of 4.37% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-32.26%	4.37%	3.45%
Organigram Global	28.14%	-13.39%	-8.67%

Aurora Cannabis has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.46, indicating that its share price is 46% more volatile than the broader market.

47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by insiders. Comparatively, 0.1% of Organigram Global shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Aurora Cannabis had 14 more articles in the media than Organigram Global. MarketBeat recorded 15 mentions for Aurora Cannabis and 1 mentions for Organigram Global. Aurora Cannabis' average media sentiment score of 0.20 beat Organigram Global's score of 0.00 indicating that Aurora Cannabis is being referred to more favorably in the media.

Company	Overall Sentiment
Aurora Cannabis	Neutral
Organigram Global	Neutral

Summary

Aurora Cannabis beats Organigram Global on 9 of the 16 factors compared between the two stocks.

How does Aurora Cannabis compare to SNDL?

Aurora Cannabis (NASDAQ:ACB) and SNDL (NASDAQ:SNDL) are related small-cap companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

SNDL has higher revenue and earnings than Aurora Cannabis. SNDL is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$247.82M	1.05	-$88.13M	-$1.41	N/A
SNDL	$677.32M	0.52	-$11.29M	-$0.06	N/A

Aurora Cannabis has a beta of 0.58, indicating that its stock price is 42% less volatile than the broader market. Comparatively, SNDL has a beta of 0.93, indicating that its stock price is 7% less volatile than the broader market.

SNDL has a consensus target price of $5.00, suggesting a potential upside of 264.96%. Given SNDL's higher probable upside, analysts plainly believe SNDL is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
SNDL	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Aurora Cannabis had 14 more articles in the media than SNDL. MarketBeat recorded 15 mentions for Aurora Cannabis and 1 mentions for SNDL. SNDL's average media sentiment score of 0.45 beat Aurora Cannabis' score of 0.20 indicating that SNDL is being referred to more favorably in the news media.

Company	Overall Sentiment
Aurora Cannabis	Neutral
SNDL	Neutral

47.6% of Aurora Cannabis shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

SNDL has a net margin of -2.36% compared to Aurora Cannabis' net margin of -32.26%. Aurora Cannabis' return on equity of 4.37% beat SNDL's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-32.26%	4.37%	3.45%
SNDL	-2.36%	-2.01%	-1.67%

Summary

Aurora Cannabis beats SNDL on 9 of the 16 factors compared between the two stocks.

How does Aurora Cannabis compare to Tilray Brands?

Tilray Brands (NASDAQ:TLRY) and Aurora Cannabis (NASDAQ:ACB) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk, media sentiment and earnings.

Aurora Cannabis has lower revenue, but higher earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	$915.45M	0.73	-$121.40M	-$1.08	N/A
Aurora Cannabis	$247.82M	1.05	-$88.13M	-$1.41	N/A

Tilray Brands has a beta of 1.9, meaning that its share price is 90% more volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.58, meaning that its share price is 42% less volatile than the broader market.

Tilray Brands currently has a consensus price target of $8.00, suggesting a potential upside of 63.93%. Given Tilray Brands' higher possible upside, research analysts clearly believe Tilray Brands is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.43
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, Tilray Brands had 4 more articles in the media than Aurora Cannabis. MarketBeat recorded 19 mentions for Tilray Brands and 15 mentions for Aurora Cannabis. Tilray Brands' average media sentiment score of 0.62 beat Aurora Cannabis' score of 0.20 indicating that Tilray Brands is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tilray Brands	6 Very Positive mention(s)	5 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Aurora Cannabis	3 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	1 Very Negative mention(s)	Neutral

9.4% of Tilray Brands shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 0.8% of Tilray Brands shares are held by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Tilray Brands has a net margin of -13.11% compared to Aurora Cannabis' net margin of -32.26%. Aurora Cannabis' return on equity of 4.37% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-13.11%	-7.76%	-5.59%
Aurora Cannabis	-32.26%	4.37%	3.45%

Summary

Tilray Brands beats Aurora Cannabis on 9 of the 16 factors compared between the two stocks.

Get Aurora Cannabis News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACB vs. The Competition

Export

Metric	Aurora Cannabis	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$255.48M	$12.52B	$7.34B	$12.72B
Dividend Yield	N/A	2.61%	2.53%	10.79%
P/E Ratio	-2.84	778.15	271.01	24.15
Price / Sales	1.05	758.07	627.95	102.20
Price / Cash	5.61	98.02	78.57	53.12
Price / Book	0.68	12.01	13.14	6.25
Net Income	-$88.13M	$2.80B	$3.46B	$347.86M
7 Day Performance	2.56%	2.85%	1.51%	0.98%
1 Month Performance	50.19%	6.52%	8.81%	5.24%
1 Year Performance	-24.34%	8.04%	26.07%	17.04%

Aurora Cannabis Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ACB Aurora Cannabis	1.9379 of 5 stars	$4.01 +1.8%	N/A	-23.3%	$255.48M	$247.82M	N/A	1,028
CGC Canopy Growth	1.2869 of 5 stars	$1.05 +1.0%	N/A	-25.7%	$470.84M	$251.01M	N/A	1,128
CRON Cronos Group	1.7834 of 5 stars	$3.22 -2.1%	$2.30 -28.6%	+35.3%	$1.19B	$146.59M	16.10	450	Options Volume
OGI Organigram Global	1.9216 of 5 stars	$1.20 -3.2%	N/A	-22.1%	$169.18M	$185.07M	2.61	1,139
SNDL SNDL	3.5729 of 5 stars	$1.33 +1.5%	$5.00 +275.9%	-42.9%	$342.34M	$677.32M	N/A	2,751

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ACB) was last updated on 8/26/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aurora Cannabis (ACB) Competitors

ACB vs. CGC, CRON, OGI, SNDL, and TLRY

How does Aurora Cannabis compare to Canopy Growth?

Summary

How does Aurora Cannabis compare to Cronos Group?

Summary

How does Aurora Cannabis compare to Organigram Global?

Summary

How does Aurora Cannabis compare to SNDL?

Summary

How does Aurora Cannabis compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACB vs. The Competition

Aurora Cannabis Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aurora Cannabis (ACB) Competitors

ACB vs. CGC, CRON, OGI, SNDL, and TLRY

How does Aurora Cannabis compare to Canopy Growth?

Which has higher earnings and valuation, CGC or ACB?

Does the media prefer CGC or ACB?

Is CGC or ACB more profitable?

Do analysts recommend CGC or ACB?

Do institutionals and insiders have more ownership in CGC or ACB?

Which has more risk and volatility, CGC or ACB?

Summary

How does Aurora Cannabis compare to Cronos Group?

Do analysts prefer CRON or ACB?

Does the media refer more to CRON or ACB?

Which has higher valuation & earnings, CRON or ACB?

Is CRON or ACB more profitable?

Do institutionals & insiders have more ownership in CRON or ACB?

Which has more volatility & risk, CRON or ACB?

Summary

How does Aurora Cannabis compare to Organigram Global?

Which has better valuation and earnings, ACB or OGI?

Do analysts rate ACB or OGI?

Is ACB or OGI more profitable?

Which has more risk and volatility, ACB or OGI?

Do insiders & institutionals hold more shares of ACB or OGI?

Does the media favor ACB or OGI?

Summary

How does Aurora Cannabis compare to SNDL?

Which has higher earnings & valuation, ACB or SNDL?

Which has more risk & volatility, ACB or SNDL?

Do analysts rate ACB or SNDL?

Does the media favor ACB or SNDL?

Do insiders and institutionals hold more shares of ACB or SNDL?

Is ACB or SNDL more profitable?

Summary

How does Aurora Cannabis compare to Tilray Brands?

Which has stronger valuation and earnings, TLRY or ACB?

Which has more risk & volatility, TLRY or ACB?

Do analysts rate TLRY or ACB?

Does the media prefer TLRY or ACB?

Do insiders and institutionals have more ownership in TLRY or ACB?

Is TLRY or ACB more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACB vs. The Competition

Aurora Cannabis Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools